2020-21 Improvements and Recommendations

Hopes were high last year when the USDA approved Georgia’s hemp production plan; however, as dozens of companies wait for approval to begin production and retail operations for the state’s fledgling Low-THC oil program, Georgia’s Supreme Court ruled that lawyers who counsel medical cannabis businesses operating in the state could face sanctions. This is just the latest bump in the road of a program trying to get on its feet since the law authorizing it was first passed in 2015.

Once again, ASA recommends Georgia get their in-state production, distribution and retail of authorized medical products off of the ground, and encourages Georgia to improve its program by strengthening product safety standards, increasing the forms of medical cannabis and medical cannabis products available to patients, and removing arbitrary limits on THC percentage.